Safety and Efficacy Study of ImCOOH Cream in Patients Suffering From Moderate Atopic Dermatitis
Status:
Terminated
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Atopic dermatitis is one of the most common skin diseases, with a lifetime prevalence of up
to 20%, and an increasing number of cases. Although there are a variety of treatments the
number of specific medications for treating this chronic disease is limited and often not
helpful, especially in more severe cases. In addition,most treatments may be used only for a
limited period or are less effective in the long term (tachyphylaxis). The development of new
compounds is mandatory for treatment of this often chronically recurring disease. The current
trial will determine the efficacy, safety and tolerability of the endogenous compound
imidazole-4-carboxylic acid (ImCOOH) administered as a topical cream twice daily for 14 days
in patients with atopic dermatitis.